The Impact of Reactogenicity After the First Dose of Recombinant Zoster Vaccine on the Physical Functioning and Quality of Life of Older Adults: An Open-Label, Phase III Trial

BACKGROUND: Herpes zoster and its related complications are associated with significant medical burden, which negatively affects quality of life and daily functioning of the patients. The recently licensed recombinant zoster vaccine (RZV) offers high efficacy but is associated with local and systemi...

Descripción completa

Detalles Bibliográficos
Autores principales: Schmader, Kenneth E, Levin, Myron J, Grupping, Katrijn, Matthews, Sean, Butuk, David, Chen, Michael, Idrissi, Mohamed El, Fissette, Laurence A, Fogarty, Charles, Hartley, Paul, Klein, Nicola P, Nevarez, Max, Uusinarkaus, Kari, Oostvogels, Lidia, Curran, Desmond
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
The Journal of Gerontology: Translational Section
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6625580/
https://www.ncbi.nlm.nih.gov/pubmed/30256905
http://dx.doi.org/10.1093/gerona/gly218

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6625580/
https://www.ncbi.nlm.nih.gov/pubmed/30256905
http://dx.doi.org/10.1093/gerona/gly218

Ejemplares similares